HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice.

Abstract
Acyclovir phosphonate [9-(3-phosphono-propyloxymethyl)guanine; SR3722] and the S enantiomer (SR3772), R enantiomer (SR3773), and R,S enantiomeric mixture (SR3745A) of ganciclovir phosphonate (9-[((+/-)-1-hydroxymethyl-3-phosphono)propyloxymethyl]guanine) were evaluated for their antiviral activities against murine cytomegalovirus. In severe combined immunodeficient mice infected with murine cytomegalovirus, SR3773 and SR3745A (12.5, 25, and 50 mg/kg of body weight per day) were superior to ganciclovir in extending the mean time to death, whereas SR3722 and SR3772 was less potent than ganciclovir. In normal BALB/c mice, SR3773 and ganciclovir were approximately equally active in preventing death. SR3773 caused renal tubular damage when administered at 50 mg/kg/day for 15 days. These results suggest that SR3773 may have potential for use in the treatment of human cytomegalovirus infections, but it may also exhibit renal toxicity.
AuthorsD F Smee, S T Sugiyama, E J Reist
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 38 Issue 9 Pg. 2165-8 (Sep 1994) ISSN: 0066-4804 [Print] United States
PMID7811037 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antiviral Agents
  • Nucleotides
  • Ganciclovir
  • Acyclovir
Topics
  • Acyclovir (analogs & derivatives, pharmacology)
  • Animals
  • Antiviral Agents (pharmacology)
  • Disease Models, Animal
  • Female
  • Ganciclovir (analogs & derivatives, pharmacology)
  • Herpesviridae Infections (drug therapy, immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, SCID
  • Microbial Sensitivity Tests
  • Muromegalovirus
  • Nucleotides (pharmacology)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: